<DOC>
	<DOCNO>NCT02762591</DOCNO>
	<brief_summary>The purpose program provide patient PDP access pimavanserin product receive market approval FDA commercially available .</brief_summary>
	<brief_title>Expanded Access Pimavanserin Patients With PD Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Pimavanserin</mesh_term>
	<criteria>1 . Patient meet one follow criterion : 1 . Patient participate previous study pimavanserin Parkinson 's disease psychosis ( PDP ) 2 . New ( `` De novo '' ) patient 2 . A clinical diagnosis Parkinson 's disease minimum duration 1 year 3 . Female patient must nonchildbearing potential 4 . Psychotic symptom must develop Parkinson 's disease diagnosis establish 5 . Patient receive stereotaxic surgery subthalamic nucleus deep brain stimulation must least 6 month postsurgery stimulator setting must stable least 1 month prior Study Day 1 ( Baseline ) must remain stable trial 6 . The patient Legally Authorized Representative ( LAR ) willing able provide consent 7 . The patient LAR willing able adequately communicate English . 1 . Patient history significant psychotic disorder prior concomitantly diagnosis Parkinson 's disease include , limited , schizophrenia bipolar disorder 2 . Patient dementia prior concurrently diagnosis Parkinson 's disease may inconsistent Parkinson 's diagnosis 3 . Patient current evidence serious and/or unstable cardiovascular , respiratory , gastrointestinal , renal , hematologic , medical disorder , include cancer malignancy , would affect patient 's ability participate program 4 . Patient myocardial infarction last six month 5 . Patient surgery plan screening , treatment , followup period Patients evaluate screening ensure criterion study participation met . These evaluation include specific measure psychosis severity , delirium , dementia , cardiovascular condition , pregnancy status . Patients may exclude study base assessment ( specifically determine baseline health psychiatric condition meet prespecified entry criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>